(Q34584089)

3 August 2017

title

Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects (English)

1 reference

3 August 2017

1 reference

1 reference

Reza Khosravan

1

1 reference

3 August 2017

Brian Grabowski

2

1 reference

3 August 2017

Jing-Tao Wu

3

1 reference

3 August 2017

Nancy Joseph-Ridge

4

1 reference

3 August 2017

Laurent Vernillet

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

22 October 2007

1 reference

British Journal of Clinical Pharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

65

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

355-363

1 reference

Febuxostat compared with allopurinol in patients with hyperuricemia and gout

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

The influence of food on the absorption and metabolism of drugs: an update

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

Effect of food on the absorption of frusemide and bumetanide in man.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

Effects of increasing solid component size of a mixed solid/liquid meal on solid and liquid gastric emptying

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

Absorption interactions with fluoroquinolones. 1995 update

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

Incidence and risk factors for gout in white men.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

Gastric emptying of solid food is most potently inhibited by carbohydrate in the canine distal ileum

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2291255

The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.03016.X

Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.03016.X

Meal composition effects on the oral bioavailability of indinavir in HIV-infected patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.03016.X

Effect of amino acids on the plasma concentration and urinary excretion of uric acid and uridine

21 January 2018

1 reference

12 December 2020

Gout and hyperuricemia

1 reference

12 December 2020

Gastrointestinal absorption of chlorothiazide: evaluation of a method using salicylazosulfapyridine and acetaminophen as the marker compounds for determination of the gastrointestinal transit time in the dog

1 reference

12 December 2020

Interactions between drugs and nutrients

1 reference

12 December 2020

CCK antagonist pre-treatment inhibits meal-enhanced drug absorption in dogs

1 reference

12 December 2020

Reduced systemic availability of an antiarrhythmic drug, bidisomide, with meal co-administration: relationship with region-dependent intestinal absorption

1 reference

12 December 2020

10.1111/J.1365-2125.2007.03016.X

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference